Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Pharmacology and Therapeutics|January 10, 2025
Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated CostsHyunwoo Koo, Tayler B Smith, John T Callaghan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast CancerMilan Radovich, Jeffrey P Solzak, Chao J Wang, et al.The Journal of Molecular Diagnostics : JMD|April 22, 2022
Analytical Validation of a Computational Method for Pharmacogenetic Genotyping from Clinical Whole Exome SequencingReynold C Ly, Tyler Shugg, Ryan Ratcliff, et al.Blood Advances|October 15, 2025
Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selectionParvathi Sudha, Phillip Pham, Wen Niu, et al.Frontiers in Oncology|July 20, 2023
Computational pharmacogenotype extraction from clinical next-generation sequencingTyler Shugg, Reynold C Ly, Wilberforce Osei, et al.Scientific Reports|July 3, 2020
Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasisJiangang Liu, Yong Beom Cho, Hye Kyung Hong, et al.Scientific Reports|October 27, 2019
Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patientsSteven M Bray, Jeeyun Lee, Seung Tae Kim, et al.Cancer Cell|December 13, 2017
Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor AbemaciclibXueqian Gong, Lacey M Litchfield, Yue Webster, et al.Pageof 2